• International Photodynamic World Congress
    Invitation
    Conference
    Sponsors
    For Authors and Presenters
    For Chairs and Committees
Boston Marriott Cambridge
Cambridge, Massachusetts, United States
28 June - 4 July 2019
Search Open Calls:    go
Print PageEmail Page

Plan to participate

Every two years, the International Photodynamic Association organizes a conference to foster scientific development and contribute to clinical practice. The 17th World Congress of the International Photodynamic Association Conference will be held in Cambridge, MA from 28 June – 4 July 2019.

Since 1986, the IPA has worked to bring together researchers and clinicians in all fields of photodynamic therapy (PDT) and photodiagnosis (PD). The conference is expected to attract physicians and scientists from the world over and is aimed at being forward-looking, projecting areas most amenable to Photodynamic Therapy as well as capturing the current status of the field. Both science and clinical topics will be covered allowing adequate times for discussion. This conference should be useful to those already in the field of PDT and also to those contemplating entering it. This is anticipated to be a particularly good forum for exchange of ideas between laboratory scientists and clinicians.

We welcome your participation in this conference. We hope to see you in Boston in June 2019!

IPA Board of Directors

   Tayyaba Hasan, President of IPA Board of Directors, Chair of IPA Congress 2019, Wellman Ctr. for Photomedicine (United States), Harvard Medical School (United States), Massachusetts General Hospital (United States)

Luis G. Arnaut, Congress Oversight Committee, Chair of IPA Congress 2017, Univ. de Coimbra (Portugal)
Vanderlei Bagnato, Congress Oversight Committee, Chair of IPA Congress 2015, Univ. de São Paulo (Brazil)
Kristian Berg, Oslo Univ. Hospital (Norway)
Stephen Bown, Univ. College London (United Kingdom)
Ji-Eun Chang, Seoul National Univ. Bundang Hospital (Korea, Republic of)
Carolyn Cross, Treasurer of IPA Board of Directors, Awards Committee, Ondine Biomedical, Inc. (Canada)
Alison Curnow, Univ. of Exeter Medical School (United Kingdom)
Vandana Grover, Secretary General of IPA Board of Directors, Pinnacle Biologics, Inc. (United States)
Michael Hamblin, Wellman Ctr. for Photomedicine (United States), Harvard Medical School (United States), Massachusetts General Hospital (United States)
Colin Hopper, Congress Oversight Committee, Eastman Dental Institute (United Kingdom), Univ. College London (United Kingdom)
Zheng Huang, Fujian Normal Univ. (China), Univ. of Colorado (United States)
David Kessel, Wayne State Univ. (United States)
Herwig Kostron, Immediate Past President of IPA Board of Directors, Congress Oversight Committee, Chair of IPA Congress 2011, Medical Univ. Innsbruck (Austria)
Edward Maytin, Lerner Research Institute - Cleveland Clinic (United States)
Harry Moseley, Univ. of Dundee (United Kingdom)
Brian Pogue, Thayer School of Engineering at Dartmouth (United States)
Patrick Ross, Main Line Health (United States)
Georg Widhalm, Medical Univ. Vienna (Austria)
Brian Wilson, Princess Margaret Cancer Ctr. (Canada), Univ. of Toronto (Canada)

IPA Scientific Advisory Committee

Mahmoud Abdelkader, German Univ. in Cairo (Egypt)
Jiro Akimoto, Tokyo Medical Univ. (Japan)
Luis G. Arnaut, Univ. de Coimbra (Portugal)
Vanderlei Bagnato, Univ. de São Paulo (Brazil)
Kristian Berg, Oslo Univ. Hospital (Norway)
Stephen Bown, Univ. College London (United Kingdom)
Myung-Gyu Choi, St. Mary's Hospital (Korea, Republic of)
Elena Filonenko, P.A. Herzen Moscow Cancer Research Institute (Russian Federation)
Arjan Griffioen, Amsterdam Univ. Medical Ctr. (Netherlands)
Syed Abrar Hasan, Alighar Muslim Univ. (India)
Harubumi Kato, Tokyo Medical Univ. (Japan)
David Kessel, Wayne State Univ. (United States)
Mlade Korbelik, Univ. of British Columbia (Canada)
Herwig Kostron, Medical Univ. of Innsbruck (Austria)
Zvi Malik, Bar-Ilan Univ. (Israel)
Keyvan Moghissi, Yorkshire Laser Ctr. (United Kingdom)
Serge Mordon, Lorraine Univ. (France)
Avigdor Scherz, Weizmann Institute of Science (Israel)
Xiuli Wang, Shanghai Skin Disease Hospital (China)
Brian Wilson, Univ. of Toronto (Canada)